IP Library Granted Patent US 9,279,156
Granted Patent B2
US 9,279,156 · App. 14/109,163 · Granted Mar 8, 2016

Methods and materials for assessing allelic imbalance

Inventors: Alexander Gutin (Salt Lake City, UT); Kirsten Timms (Salt Lake City, UT); Jerry Lanchbury (Salt Lake City, UT)
Assignee: MYRIAD GENETICS, INC.
C12Q1/6883C12Q1/6827C12Q1/6858C12Q1/6874G06F19/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,279,156
App. No.
14/109,163
Granted
Mar 8, 2016
Kind
B2
Abstract

Methods and systems for detecting allelic imbalance using nucleic acid sequencing are provided.

Claims (25)

1. An in vitro method for detecting homozygosity at a plurality of single nucleotide polymorphism loci, comprising:

(1) providing a formalin-fixed paraffin-embedded sample comprising at least one tumor cell obtained from a patient;

(2) enriching the sample in (1) for test DNA molecules each comprising at least one locus from the plurality of single nucleotide polymorphism loci, wherein the plurality of single nucleotide polymorphism loci comprises at least 5,000 single nucleotide polymorphism loci and wherein there is at least one single nucleotide polymorphism locus located on average every 500 kb within each chromosome; and

(3) sequencing the test DNA molecules to determine whether each locus in the plurality of single nucleotide polymorphism loci is homozygous.

2. The method of claim 1 , wherein the plurality of single nucleotide polymorphism loci comprises at least 10,000 single nucleotide polymorphism loci.

3. The method of claim 1 , wherein the plurality of single nucleotide polymorphism loci comprises at least 50,000 single nucleotide polymorphism loci.

4. The method of claim 1 , wherein there is at least one single nucleotide polymorphism locus located on average every 100 kb within each chromosome.

5. The method of claim 1 , wherein there is at least one single nucleotide polymorphism locus located on average every 50 kb within each chromosome.

6. The method of claim 1 , wherein there is at least one single nucleotide polymorphism locus located on average every 10 kb within each chromosome.

7. The method of claim 1 , wherein the genomic spacing of the plurality of single nucleotide polymorphism loci is less than or equal to 50%.

8. The method of claim 1 , wherein the genomic spacing of the plurality of single nucleotide polymorphism loci is less than or equal to 25%.

9. The method of claim 1 , wherein the genomic spacing of the plurality of single nucleotide polymorphism loci is less than or equal to 10%.

10. A system for detecting homozygosity at a plurality of single nucleotide polymorphism loci, comprising:

(1) a sample analyzer for

(a) enriching a formalin-fixed paraffin-embedded sample comprising at least one tumor cell obtained from a patient for test DNA molecules each comprising at least one locus from the plurality of single nucleotide polymorphism loci, wherein the plurality of single nucleotide polymorphism loci comprises at least 5,000 single nucleotide polymorphism loci and wherein there is at least one single nucleotide polymorphism locus located on average every 500 kb within each chromosome; and

(b) sequencing the test DNA molecules to produce a plurality of quantitative signals representing the alleles for each locus in the plurality of single nucleotide polymorphism loci present in the test DNA molecules; and

(2) a computer program for analyzing the plurality of quantitative signals to determine whether each locus in the plurality of single nucleotide polymorphism loci is homozygous.

11. The method of system 10 , wherein the plurality of single nucleotide polymorphism loci comprises at least 10,000 single nucleotide polymorphism loci.

12. The method of system 10 , wherein the plurality of single nucleotide polymorphism loci comprises at least 50,000 single nucleotide polymorphism loci.

13. The method of system 10 , wherein there is at least one single nucleotide polymorphism locus located on average every 100 kb within each chromosome.

14. The method of system 10 , wherein there is at least one single nucleotide polymorphism locus located on average every 50 kb within each chromosome.

15. The method of system 10 , wherein there is at least one single nucleotide polymorphism locus located on average every 10 kb within each chromosome.

16. The method of system 10 , wherein the genomic spacing of the plurality of single nucleotide polymorphism loci is less than or equal to 50%.

17. The method of system 10 , wherein the genomic spacing of the plurality of single nucleotide polymorphism loci is less than or equal to 25%.

18. The method of system 10 , wherein the genomic spacing of the plurality of single nucleotide polymorphism loci is less than or equal to 10%.

Assignments (7)
RELEASE OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (064235/0032) Recorded Aug 1, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: MYRIAD GENETICS, INC.; MYRIAD WOMEN’S HEALTH, INC.; GATEWAY GENOMICS, LLC; ASSUREX HEALTH, INC.
Reel/Frame 072331/0215 →
SECURITY INTEREST Recorded Aug 1, 2025
From: MYRIAD GENETICS, INC.; MYRIAD GENETIC LABORATORIES, INC.; MYRIAD WOMEN’S HEALTH, INC.; ASSUREX HEALTH, INC.; GATEWAY GENOMICS, LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP, AS ADMINISTRATIVE AGENT FOR SECURED PARTIES
Reel/Frame 072309/0932 →
RELEASE OF SECURITY INTEREST Recorded Jul 10, 2023
From: JPMORGAN CHASE BANK, N.A.
To: MYRIAD GENETICS, INC.; CRESCENDO BIOSCENCE, INC.; MYRIAD RBM, INC.; MYRIAD WOMEN'S HEALTH, INC.
Reel/Frame 064239/0091 →
PATENT SECURITY AGREEMENT Recorded Jul 7, 2023
From: MYRIAD GENETICS, INC.; MYRIAD WOMEN'S HEALTH, INC.; GATEWAY GENOMICS, LLC; ASSUREX HEALTH, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 064235/0032 →
SECURITY INTEREST Recorded Dec 27, 2016
From: MYRIAD GENETICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 041198/0578 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2014
From: GUTIN, ALEXANDER; TIMMS, KIRSTEN; LANCHBURY, JERRY
To: MYRIAD GENETICS, INC.
Reel/Frame 032179/0918 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2014
From: GUTIN, ALEXANDER; TIMMS, KIRSTEN; LANCHBURY, JERRY
To: MYRIAD GENETICS, INC.
Reel/Frame 032180/0001 →
Continuity (3)
Continuation PCTUS2012042668 · Jun 15, 2012
Provisional Application 61498418 · Jun 17, 2011
Related Publication 20140162886A1 · Jun 12, 2014